Breast Cancer Foundation NZ
An exploration into the gene that determines whether hormone therapy works for certain individuals
May 2016
Belinda Scott Fellowship
What is the problem and who is affected?
FOXA1 gene, and its mutations, have been suggested to determine whether or not a breast cancer patient will respond to hormone therapy.
What is this research hoping to achieve?
Dr Muthukaruppa's research will explore the role of FOXA1 gene variant in breast cancer. This information will allow doctors to better personalise cancer treatment so that each patient will receive the medicine that will work best for them.
-
DecemberBelinda Scott Fellowship
Search for TDP1 and TDP2 inhibitors
-
AugustResearch Grant
A clinical study using personalised blood tests to monitor tumour DNA
-
AugustResearch Grant
A screening test to determine which HER2+ breast cancer patients will benefit from Kadcyla
-
AugustResearch Grant
A new antibody targeting hard-to-treat cancers
-
AugustResearch Grant
A new test to identify patients who will suffer from severe side-effects on capecitabine
-
JuneResearch Grant
Using the Breast Cancer Foundation National Register for targeted molecular research
-
MayBelinda Scott Fellowship
An exploration into the gene that determines whether hormone therapy works for certain individuals
-
MayBelinda Scott Fellowship
An investigation into the potential of low-oxygen-targeted drugs as a treatment for breast cancer
-
MayResearch Grant
MAGLEV Study
-
MayResearch Grant
BCAR
-
MarchResearch Grant
ELIMINATE Trial
-
MarchMedical Equipment
Improving cardiac safety for breast cancer patients through a Deep Inspiration Breath Hold (DIBH)
-
MarchMedical Equipment
Stereotactic brain radiotherapy
-
FebruaryResearch Grant
Developing guidelines for breast conserving surgery
-
FebruaryResearch Grant
Exploring cell nucleus changes as drug targets for advanced breast cancer